SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa)
virus

SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa)

EVAg
Produced by
: RKI
Shipping From
: Berlin - DE

Product Description

Ref-SKU:
009V-05256
SARS-COV-2, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa). Infectious cell culture supernatant. Product only available via TNA.
Product Risk Group: 
RG3
ICTV Taxonomy: 
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus / Sarbecovirus / Severe acute respiratory syndrome-related coronavirus
Virus name: 
SARS-CoV-2
HUMAN
2021
GERMANY (LINEAGE B.1.617.1
Kappa)

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Not tested

Unit definition: 
1 vial, 1 mL infectious cell culture supernatant

In stock

950,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Virus host type: 
Human virus
Infectivity Test: 
TCID50
Viral titer: 
7,9 x 10^5 TCID50/ml
Production cell line: 
VERO-TMPRSS2
Virus Cultivability: 
Cultivable virus
Passage: 
2
Shipping conditions: 
Dry ice
IATA Classification: 
Category A, UN2814

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Monday, 10 May, 2021
Country of collection: 
Germany